Yvon Bastien
Presidente presso PainCeptor Pharma Corp.
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Yvon Bastien
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Public Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yvon Bastien tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
SPECTRAL MEDICAL INC. | Medical Specialties | Corporate Officer/Principal | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
Montréal Exchange, Inc.
Montréal Exchange, Inc. Investment Banks/BrokersFinance Montréal Exchange, Inc. engages in the operation and development of market and clearing services for Canadian and international clients and to commercialize internally developed technology solutions. The Group operates in two segments, namely, Exchange and Clearing House. The Exchange segment acts as the only standardized financial derivatives exchange in Canada, providing a complete range of equity, index and interest rate derivatives. The Clearing House segment acts as clearing house and guarantor for derivative instruments traded at the MX and certain other derivative instruments from the over-the-counter market. The company is headquartered in Montreal, Canada. | Investment Banks/Brokers | Director/Board Member | |
Futurion 1 SA
Futurion 1 SA Financial ConglomeratesFinance Futurion 1 SA engages in the provision of financial advisory services. The company was founded in 1990 and is headquartered in Warsaw, Poland. | Financial Conglomerates | Corporate Officer/Principal | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Wellcome Trust Technology Transfer
Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer (Wellcome Trust Technology Transfer) is a venture capital subsidiary of The Wellcome Trust Ltd. founded in 1992 by Graham Eric Fagg. The firm is headquartered in London. | Investment Managers | Founder | |
Desjardins Securities, Inc.
Desjardins Securities, Inc. Investment Banks/BrokersFinance Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). | Investment Banks/Brokers | Corporate Officer/Principal | |
CIECH S.A. | Chemicals: Specialty | Director/Board Member | |
McGill University | College/University | Masters Business Admin Undergraduate Degree | |
BASF Performance Products Ltd. (United Kingdom)
BASF Performance Products Ltd. (United Kingdom) Chemicals: SpecialtyProcess Industries Basf Performance Products Ltd. manufactures chemical products. It offers dyes and pigments, plastics, and other inorganic basic chemicals. The company was founded on September 12, 1996 and is headquartered in Cheadle, the United Kingdom. | Chemicals: Specialty | Corporate Officer/Principal | |
Bank Pocztowy SA
Bank Pocztowy SA Major BanksFinance Bank Pocztowy SA is a universal bank engages in the provision of financial services in post offices and branches across the country. Its services include personal accounts, withdrawals and payment on account, deposits, loans, credit cards, savings account, insurance, electronic banking, and investments. The company was founded in 1990 and is headquartered in Bydgoszcz, Poland. | Major Banks | Director/Board Member | |
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor | |
Alta Genetics, Inc.
Alta Genetics, Inc. BiotechnologyHealth Technology Alta Genetics, Inc. engages in the provision of reproductive genetics and management services. Its products include Alta 511 SexedUltra, Alta G-Star, Alta FUTURE STAR, VAS DairyCom, and Alta COW WATCH. The company is headquartered in Rocky View County, Canada. | Biotechnology | Corporate Officer/Principal | |
Accolade Group
Accolade Group Apparel/FootwearConsumer Non-Durables Accolade Group is a Canadian company that distributes apparel and accessories. | Apparel/Footwear | Corporate Officer/Principal | |
University of Alberta | College/University | Masters Business Admin | |
University of Toronto | College/University | Masters Business Admin | |
University of Montréal | College/University | Doctorate Degree | |
University of Calgary | College/University | Undergraduate Degree | |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member Director/Board Member | |
University College London | College/University | Doctorate Degree | |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Investment Committee Member | |
Kernel Management Partners Ltd.
Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Investment Managers | Private Equity Investor | |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Generic | Director/Board Member | |
BDM SA | Director/Board Member | ||
Arab National Bank Investment Co.
Arab National Bank Investment Co. Investment ManagersFinance Arab National Bank Investment Co. (ANB Invest) is wholly-owned subsidiary of Arab National Bank in Saudi Arabia, acting as its sole investment arm. Founded in 2008, the firm is headquartered in Riyadh and offers the full spectrum of investment services both conventional and Shariah-compliant, to all client categories including private & institutional investors. ANB Invest’s asset management division offers a wide range of mutual funds in addition to private portfolios management services in accordance with the various risk appetites and liquidity needs of its individual & institutional clients. | Investment Managers | Chief Executive Officer | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
STOPKLATKA SA | Broadcasting | Director/Board Member | |
M4B S.A. | Miscellaneous Manufacturing | Director/Board Member | |
ROBYG SA | Real Estate Development | Director/Board Member | |
Baltic Brokers AB
Baltic Brokers AB Financial ConglomeratesFinance Baltic Brokers AB provides investment services. The private company is based in Sundbyberg, Sweden and has subsidiaries in Sweden. | Financial Conglomerates | Chief Executive Officer | |
OM Finance Spzoo
OM Finance Spzoo Miscellaneous Commercial ServicesCommercial Services OM Finance Spzoo provides consulting and investment services. The private company is based in Gdansk, Poland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Miedzynarodowe Targi Gdanskie SA | Director/Board Member | ||
Inveno Sp zoo
Inveno Sp zoo Information Technology ServicesTechnology Services Inveno Sp zoo engages in the provision of information technology services. Its offers includes creating online stores, building computer game engines and websites, and IT support for companies. The company was founded on June 28, 2013 and is headquartered in Warsaw, Poland. | Information Technology Services | Chief Executive Officer | |
Arab National Investment Co. | Director/Board Member | ||
ImmunoBiochem Corp.
ImmunoBiochem Corp. BiotechnologyHealth Technology ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub. | Biotechnology | Director/Board Member | |
Pomorski Regionalny Fundusz Poreczen Kredytowych Sp Z O O | Director/Board Member | ||
Gdansk Business Club Council | Corporate Officer/Principal | ||
Theatrum Gedanense Foundation | Corporate Officer/Principal | ||
Aegera Pharmaceuticals | Director/Board Member | ||
University of Gdansk | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Canada | 20 |
Polonia | 14 |
Regno Unito | 9 |
Svezia | 5 |
Arabia Saudita | 3 |
Settori
Health Technology | 15 |
Finance | 13 |
Consumer Services | 10 |
Process Industries | 3 |
Technology Services | 3 |
Posizioni
Director/Board Member | 43 |
Corporate Officer/Principal | 20 |
Chief Executive Officer | 11 |
Undergraduate Degree | 9 |
Private Equity Investor | 5 |
Contatti più connessi
- Borsa valori
- Insiders
- Yvon Bastien
- Connessioni Società